Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Vincent Camus, Elodie Bohers, Sydney Dubois, Hervé Tilly & Fabrice Jardin. (2018) Circulating tumor DNA: an important tool in precision medicine for lymphoma. Expert Review of Precision Medicine and Drug Development 3:1, pages 11-21.
Read now
Read now
Vincent Camus, Fabrice Jardin & Herve Tilly. (2017) The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential. Expert Review of Molecular Diagnostics 17:6, pages 557-566.
Read now
Read now
Articles from other publishers (32)
Seung Ha Cha, Ka-Won Kang, Na Yeon Han, Yongwon Cho, Deuk Jae Sung, Beom Jin Park, Min Ju Kim, Ki Choon Sim, Yeo Eun Han & Hwa Jung Sung. (2023) Development and validation of CT‑based radiomics model of PET-negative residual CT masses: a potential biomarker for predicting relapse‑free survival in non-Hodgkin lymphoma patients showing complete metabolic response. Abdominal Radiology.
Crossref
Crossref
Lorenz Thurner, Marita Ziepert, Christian Berdel, Christian Schmidt, Peter Borchmann, Dominic Kaddu-Mulindwa, Andreas Viardot, Mathias Witzens-Harig, Judith Dierlamm, Mathias Haenel, Bernd Metzner, Gerald Wulf, Eva Lengfelder, Ulrich B. Keller, Norbert Frickhofen, Maike Nickelsen, Tobias Gaska, Frank Griesinger, Rolf Mahlberg, Reinhard Marks, Ofer Shpilberg, Hans-Walter Lindemann, Martin Soekler, Ludwig Fischer von Weikersthal, Michael Kiehl, Eva Roemer, Martin Bentz, Beate Krammer-Steiner, Ralf Trappe, Peter de Nully Brown, Massimo Federico, Francesco Merli, Marianne Engelhard, Bertram Glass, Norbert Schmitz, Lorenz Truemper, Moritz Bewarder, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Andreas Rosenwald, Bettina Altmann, Heinz Schmidberger, Jochen Fleckenstein, Markus Loeffler, Viola Poeschel & Gerhard Held. (2023) Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study. HemaSphere 7:7, pages e904.
Crossref
Crossref
Niklas Benedikt Pepper, Michael Oertel, Stephan Rehn, Carsten Kobe & Hans Theodor Eich. (2023) Modern PET-Guided Radiotherapy Planning and Treatment for Malignant Lymphoma. Seminars in Nuclear Medicine 53:3, pages 389-399.
Crossref
Crossref
Belinda A. Campbell, Richard L. Bakst, Sarah A. Milgrom & John F. Seymour. (2022) Balancing the Therapeutic Ratio in DLBCL Requires Appropriate, Individualized Patient Selection Rather Than Broad Elimination of Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 113:3, pages 479-488.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Athanassios Liaskas, Alexia Piperidou, Maria Ioakim & Vassilios Prassopoulos. 2022. Artificial Intelligence in PET/CT Oncologic Imaging. Artificial Intelligence in PET/CT Oncologic Imaging
109
151
.
Elizabeth H Phillips, Rohan Iype & Andrew Wirth. (2021) PET-guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. The British Journal of Radiology 94:1127.
Crossref
Crossref
Andrew WirthN. George Mikhaeel. (2021) PET response–guided radiotherapy for advanced DLBCL?. Blood 137:7, pages 866-867.
Crossref
Crossref
Andrew Wirth, N. George Mikhaeel, Berthe M.P. Aleman, Chelsea C. Pinnix, Louis S. Constine, Umberto Ricardi, Tim M. Illidge, Hans Theodor Eich, Bradford S. Hoppe, Bouthaina Dabaja, Andrea K. Ng, Youlia Kirova, Anne Kiil Berthelsen, Karin Dieckmann, Joachim Yahalom & Lena Specht. (2020) Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines. International Journal of Radiation Oncology*Biology*Physics 107:5, pages 909-933.
Crossref
Crossref
Brandon S. Imber & Joachim Yahalom. (2020) Radiotherapy for Non-Hodgkin Lymphomas. The Cancer Journal 26:3, pages 217-230.
Crossref
Crossref
Susanna Tokola, Hanne Kuitunen, Taina Turpeenniemi‐Hujanen & Outi Kuittinen. (2020) Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients. Cancer Medicine 9:6, pages 1966-1977.
Crossref
Crossref
Vincent Camus & Fabrice Jardin. (2019) Cell-free DNA and the monitoring of lymphoma treatment. Pharmacogenomics 20:18, pages 1271-1282.
Crossref
Crossref
N. George Mikhaeel, Sarah A. Milgrom, Stephanie Terezakis, Anne Kiil Berthelsen, David Hodgson, Hans Theodor Eich, Karin Dieckmann, Shu-nan Qi, Joachim Yahalom & Lena Specht. (2019) The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology*Biology*Physics 104:3, pages 501-512.
Crossref
Crossref
Andrew Wirth, H. Miles Prince, Daniel Roos, John Gibson, Peter O'Brien, Diana Zannino, Bereha Khodr, Janey M. Stone, Sidney Davis & Mark Hertzberg. (2019) A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03). International Journal of Radiation Oncology*Biology*Physics 103:5, pages 1158-1166.
Crossref
Crossref
Christopher Melani, Wyndham H. Wilson & Mark Roschewski. (2018) Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA. Best Practice & Research Clinical Haematology 31:3, pages 285-292.
Crossref
Crossref
Aatif Parvez, Noam Tau, Douglas Hussey, Manjula Maganti & Ur Metser. (2018) 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival. Annals of Nuclear Medicine 32:6, pages 410-416.
Crossref
Crossref
Øystein Fluge, Bård Mannsåker, Anders Torp, Ingvil Mjaaland, Lars Helgeland, Jan Klos, Olav Mella, Sigbjørn Berentsen & Peter Meyer. (2018) Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study. Clinical Lymphoma Myeloma and Leukemia 18:2, pages 125-135.e3.
Crossref
Crossref
Theodoros P. Vassilakopoulos & Vassilios K. Prassopoulos. 2018. Imaging in Clinical Oncology. Imaging in Clinical Oncology
619
647
.
Vijaya R. Bhatt & James O. Armitage. (2017) Staging and restaging patients with lymphoma — a better approach?. Nature Reviews Clinical Oncology 14:9, pages 527-528.
Crossref
Crossref
Naveen M. KulkarniDaniella F. PinhoSrikala NarayananAvinash R. KambadakoneJeremy S. AbramsonDushyant V. Sahani. (2017) Imaging for Oncologic Response Assessment in Lymphoma. American Journal of Roentgenology 208:1, pages 18-31.
Crossref
Crossref
N. George Mikhaeel & Lena Specht. 2017. Radiation Therapy in Hematologic Malignancies. Radiation Therapy in Hematologic Malignancies
29
43
.
Silvia Morbelli, Selene Capitanio, Fabrizio De Carli, Francesca Bongioanni, Enrico De Astis, Maurizio Miglino, Maria Teresa Verardi, Ambra Buschiazzo, Francesco Fiz, Cecilia Marini, Elena Pomposelli & Gianmario Sambuceti. (2015) Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission. European Journal of Nuclear Medicine and Molecular Imaging 43:2, pages 232-239.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Vassilios K. Prassopoulos, Phoivi Rondogianni, Sofia N. Chatziioannou, Vasileios I. Telonis & Effimia P. Vrakidou. 2016. PET/CT in Lymphomas. PET/CT in Lymphomas
111
171
.
Bouthaina S. Dabaja, Ranjana Advani, David C. Hodgson, Sughosh Dhakal, Christopher R. Flowers, Chul S. Ha, Bradford S. Hoppe, Nancy P. Mendenhall, Monika L. Metzger, John P. Plastaras, Kenneth B. Roberts, Ronald Shapiro, Sonali M. Smith, Stephanie A. Terezakis, Karen M. Winkfield, Anas Younes & Louis S. Constine. (2015) ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. American Journal of Clinical Oncology 38:6, pages 610-620.
Crossref
Crossref
Sarah A. Johnson, Anita Kumar, Matthew J. Matasar, Heiko Schöder & Jürgen Rademaker. (2015) Imaging for Staging and Response Assessment in Lymphoma. Radiology 276:2, pages 323-338.
Crossref
Crossref
David M. Kurtz, Michael R. Green, Scott V. Bratman, Florian SchererChih Long LiuChristian A. KunderKazuhiro TakahashiCynthia GloverColm KeaneShingo KihiraBrendan VisserJason CallahanKatherine A. KongMalek FahamKaren S. CorbelliDavid MiklosRanjana H. AdvaniRonald LevyRodney J. HicksMark HertzbergRobert S. OhgamiMaher K. GandhiMaximilian Diehn & Ash A. Alizadeh. (2015) Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood 125:24, pages 3679-3687.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Vassilios Prassopoulos, Phoivi Rondogianni, Sofia Chatziioannou, Kostas Konstantopoulos & Maria K. Angelopoulou. (2015) Role of FDG-PET/CT in staging and first-line treatment of Hodgkin and aggressive B-cell lymphomas. memo - Magazine of European Medical Oncology 8:2, pages 105-114.
Crossref
Crossref
Susan M. Hiniker, Erqi L. Pollom, Michael S. Khodadoust, Margaret M. Kozak, Guofan Xu, Andrew Quon, Ranjana H. Advani & Richard T. Hoppe. (2015) Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era. International Journal of Radiation Oncology*Biology*Physics 92:1, pages 99-106.
Crossref
Crossref
Hugo J.A. Adams, John M.H. de Klerk, Rob Fijnheer, Ben G.F. Heggelman, Stefan V. Dubois, Rutger A.J. Nievelstein & Thomas C. Kwee. (2015) Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET–Based Complete Response After First-Line R-CHOP Therapy. Journal of Computer Assisted Tomography 39:5, pages 810-815.
Crossref
Crossref
Sally F. BarringtonN. George MikhaeelLale KostakogluMichel MeignanMartin HutchingsStefan P. MüellerLawrence H. SchwartzEmanuele ZuccaRichard I. FisherJudith TrotmanOtto S. HoekstraRodney J. HicksMichael J. O'DohertyRoland HustinxAlberto BiggiBruce D. Cheson. (2014) Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology 32:27, pages 3048-3058.
Crossref
Crossref
Dina M. ABO-Sheisha & Omnia Abdel Fattah. (2014) Prognostic evaluation of PET/CT in residual post-chemotherapy masses in patients with diffuse large B-cell lymphoma and its impact on survival. The Egyptian Journal of Radiology and Nuclear Medicine 45:3, pages 921-928.
Crossref
Crossref
Gerhard HeldNiels MurawskiMarita ZiepertJochen FleckensteinViola PöschelCarsten ZwickJörg BittenbringMathias HänelSibylla WilhelmJörg SchubertNorbert SchmitzMarkus LöfflerChristian RübeMichael Pfreundschuh. (2014) Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell Lymphoma. Journal of Clinical Oncology 32:11, pages 1112-1118.
Crossref
Crossref
Belinda A. Campbell. (2013) The Role of Radiation Therapy in the Treatment of Stage I-II Diffuse Large B-Cell Lymphoma. Current Hematologic Malignancy Reports 8:3, pages 236-242.
Crossref
Crossref